NWS
88
5
FFIV
58
-3
TRIP
55
-3
NAVI
52
2
AMT
58
3
HBI
45
-3
EXPD
53
3
HP
52
2
WMB
63
3
PSA
43
2
FRT
55
-3
STZ
60
-4
SIG
55
5
PYPL
39
2
TXT
73
4
REGN
62
-3
NWSA
82
-2
AMZN
60
-3
SRCL
55
2
PM
56
-2
NWS
88
5
FFIV
58
-3
TRIP
55
-3
NAVI
52
2
AMT
58
3
HBI
45
-3
EXPD
53
3
HP
52
2
WMB
63
3
PSA
43
2
FRT
55
-3
STZ
60
-4
SIG
55
5
PYPL
39
2
TXT
73
4
REGN
62
-3
NWSA
82
-2
AMZN
60
-3
SRCL
55
2
PM
56
-2
Financhill
Back

Cytokinetics Stock Predictions

FREE Report: Could these High Yield Stocks wreck your retirement?

Get Your Copy of "20 High-Yield Dividend Stocks that Could Ruin Your Retirement" Here.
Buy
57

CYTK
Cytokinetics

Last Price:
54.43
Seasonality Move:
8.96%

7 Day Trial

ALL ACCESS PASS

$ 7

This New Idea is Set to Shock the World

Click here to learn all the details.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 13.6% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $54.40. The Score for CYTK is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 13.6% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Buy
57
Cytokinetics (CYTK) is a Buy

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • The current trend is relatively stagnant and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
5.7B
Price in USD:
54.40
Volume:
487.23K
Beta:
1.45

Technical Analysis

SMA50:
56.72
SMA100:
63.87
SMA200:
56.39
52-Wk Change:
63.07%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 54.40 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 54.02 52.73 54.41 52.67
Jun-14 52.23 53.93 54.35 51.87
Jun-17 53.07 52.78 53.77 52.08
Jun-18 52.71 51.94 53.44 51.57
Jun-20 51.81 51.81 52.88 51.50
Jun-21 52.21 53.55 53.80 51.62
Jun-24 53.75 53.85 54.57 53.01
Jun-25 54.02 52.87 54.77 52.72
Jun-26 52.50 51.80 52.50 50.82
Jun-27 51.86 53.78 54.04 51.29
Jun-28 53.75 54.21 54.66 52.94
Jul-1 53.83 54.70 55.86 53.24
Jul-2 54.97 54.84 54.97 53.39
Jul-3 55.40 54.40 55.50 54.19

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.15 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.